Laryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year
Launched by OSLO UNIVERSITY HOSPITAL · Jun 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a common condition in infants called laryngomalacia, which can cause noisy breathing (stridor) and sometimes leads to breathing difficulties and sleep problems. The researchers want to find out if special sleep tests can help identify which children might benefit from surgery to improve their breathing. They will follow up with the children after a few weeks and again after a year to see how they are doing.
Eligible participants are children aged 7 days to 1 year who have laryngomalacia, show stridor, and have breathing difficulties. There are no exclusions based on other health conditions. If your child participates, they will undergo sleep examinations at home, and their quality of life will be assessed through a simple questionnaire. This study aims to use new technology, including artificial intelligence, to better understand the condition and its effects on children’s lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • laryngomalacia
- • stridor
- • breathing difficulties
- Exclusion Criteria:
- • - none
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Oslo, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported